PGNYProgyny, Inc.
Is it growing?
Growing: earnings up +56% year on year and operating margin widening (+2.4 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +24% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 8.5% now against 6.1% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is PGNY growing?
Progyny, Inc. has grown revenue 11% a year over three years and 24% a year over five, with earnings per share compounding at −82%.
Revenue growth, 3-year annual rate · Healthcare Plans median +7.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +24%
Revenue growth, 5-year rate · +11% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- −82%
Earnings per share, 3-year rate · revenue +11% · earnings lagged revenue: the growth is costing something
- Years of annual history on file
- 9
Years of annual history on file · FY2017 to FY2025, as filed
Details›
- Revenue FY2021
- $501M
- Revenue FY2022
- $787M
- Revenue FY2023
- $1.09B
- Revenue FY2024
- $1.17B
- Revenue FY2025
- $1.29B
Annual income statements as filed with the SEC.